Dr. Treon presents findings from the whole genome sequencing project at the Annual Meeting of the International Waldenstrom’s Macroglobulinemia Foundation in Tampa, FL

May 17, 2014, Tampa, Florida: Nearly 300 patients and caregivers were present for the afternoon session in which Dr. Treon discussed the diagnostic and treatment implications of the MYD88 L265P and CXCR4 WHIM mutations that were discovered by the Bing Center for WM, and reported in two publications in BLOOD. Dr. Treon also discussed the results of the clinical trial with ibrutinib in WM patients, and the impact of CXCR4 mutations on response outcome.

 

The 2014 IWMF Ed Forum was held in Tampa, FL, May 16-18, 2014 at the Marriott Renaissance Hotel. You may see Dr. Steven Treon's presentation on "Genomic Advances in the Treatment of WM" in its entirely here.

 

The IWMF's annual Educational Forum is a unique opportunity for patients and caregivers to learn about our disease from specialists in Waldenstrom’s macroglobulinemia (WM) who are involved in many areas of clinical practice and research. Held in a different part of the United States every year, the “Ed Forum” offers something for everyone, no matter what your experience or level of knowledge.

To learn more about the IWMF Ed Forum please visit http://www.iwmf.com/news-and-events/iwmf-educational-forum